Genital warts, caused by HPV, are prevalent among sexually active individuals, with imiquimod cream being an FDA-approved treatment for external genital and perianal HPV infections. Imiquimod demonstrates similar efficacy to cryotherapy and lower recurrence rates compared to other treatments, stimulating the immune response by activating toll-like receptors. It is recommended by European and CDC treatment guidelines for managing genital warts due to its effectiveness and lower incidence of irritation.